<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02021045</url>
  </required_header>
  <id_info>
    <org_study_id>1706/2013</org_study_id>
    <nct_id>NCT02021045</nct_id>
  </id_info>
  <brief_title>Cerebral Microembolism During Hemodialysis</brief_title>
  <official_title>Quantity, Quality and Laterality of Cerebral Microembolism During Veno-Venous Hemodialysis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is increasing evidence that renal replacement therapy (= continuous veno-venous
      hemodialysis) generates cerebral microembolism which is detectable on transcranial Doppler
      ultrasound.

      The aim of this study is to monitor patients with transcranial Doppler under two conditions:
      during hemodialysis and in a hemodialysis-free interval (in each period cerebral embolic load
      is detected during 30 minutes).

      The study hypothesis is that during hemodialysis the cerebral embolic load is significantly
      higher than in the hemodialysis-free interval.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quantity of cerebral embolic load</measure>
    <time_frame>30 minutes</time_frame>
    <description>Cerebral embolic load is measured in a 30 minutes-interval during hemodialysis and in a hemodialysis-free interval.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality and laterality of cerebral embolic load</measure>
    <time_frame>30 minutes</time_frame>
    <description>Quality (solid vs. gaseous) and laterality (left vs. right hemispheric dominance) of cerebral embolic load is measured in a 30 minutes-interval during hemodialysis and in a hemodialysis-free interval.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Complication of Dialysis</condition>
  <condition>Thrombus Due to Renal Dialysis Device, Implant, or Graft</condition>
  <condition>Cerebral Embolism</condition>
  <arm_group>
    <arm_group_label>Patient on Hemodialysis</arm_group_label>
    <description>Renal hemodialysis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patient in a hemodialysis-free interval</arm_group_label>
    <description>No Renal hemodialysis</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Renal hemodialysis (Fresenius 2008K, Bad Homburg, Germany)</intervention_name>
    <description>Renal replacement therapy is frequently used in patients with renal failure in order to eliminate substances obligatory excreted by the urine.</description>
    <arm_group_label>Patient on Hemodialysis</arm_group_label>
    <other_name>Continuous veno-venous hemodialysis</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population incloses patients who are in renal failure needing renal replacement
        therapy under intensive care conditions.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Renal replacement therapy (continuous veno-venous hemodilalysis) on the in-house
             intensive care unit

          -  Age &gt; 18yrs and &lt; 90yrs

        Exclusion Criteria:

          -  Absent informed consent

          -  Preexistent neurological morbidity

          -  Neurocognitive disturbances

          -  Carotid artery stenosis &gt; 70%

          -  Patent foramen ovale

          -  Treatment with other extracorporeal devices

          -  Cardial pathology (valvular heart disease, prosthesis, endocarditis)

          -  Pregnancy, drug abuse

          -  Inclusion in an other clinical study

          -  Allergy against materials of the medical device used in the study (transcranial
             Doppler) or temporal skin/bone lesions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gabor Erdoes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Vienna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2013</study_first_submitted>
  <study_first_submitted_qc>December 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 27, 2013</study_first_posted>
  <last_update_submitted>March 3, 2016</last_update_submitted>
  <last_update_submitted_qc>March 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Dr. Gabor Erdoes</investigator_full_name>
    <investigator_title>Dr Gabor Erdoes</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Intracranial Embolism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

